RE:RE:RE:RE:RE:sSort or soluble sortilinMaybe it was posted here before by somebody else, but Thera filed for a patent specefically on the inhibition of vasculogenic mimicry. The patent covers not only TH1902, but a wide array of peptides and possible PDC. I would really like to hear what Beliveau and Marsolais would have to say about soluble sortilin.
https://patentscope.wipo.int/search/en/detail.jsf?docId=WO2020037434